Mycobacterium avium intracellulare complex infection in HIV-infected children
- PMID: 8099487
- DOI: 10.1097/00002030-199304000-00009
Mycobacterium avium intracellulare complex infection in HIV-infected children
Abstract
Objective: To describe the incidence of, and risk factors for, Mycobacterium avium intracellulare complex (MAC) infection in HIV-infected children.
Setting: University-affiliated children's hospital.
Design and methods: The medical records of 70 HIV-infected infants and children were reviewed retrospectively.
Results: Seven children (10% of the HIV-infected patients; 18% of those with AIDS) developed disseminated MAC (dMAC). An additional seven children had gastrointestinal colonization with MAC. Risk of dMAC was associated with increasing age, decreasing CD4 cell count, and (possibly) long-term steroid therapy.
Conclusions: HIV-infected children are at risk of developing dMAC. Children older than 60 months and those with a CD4 cell count < 100 x 10(6)/l are most at risk.
Similar articles
-
A comparative study of transfusion-acquired human immunodeficiency virus-infected children with and without disseminated Mycobacterium avium complex.Pediatr Infect Dis J. 1994 Jun;13(6):484-8. doi: 10.1097/00006454-199406000-00004. Pediatr Infect Dis J. 1994. PMID: 7915834
-
Disseminated Mycobacterium avium complex infection: clinical identification and epidemiologic trends.J Infect Dis. 1992 Mar;165(3):577-80. doi: 10.1093/infdis/165.3.577. J Infect Dis. 1992. PMID: 1347060
-
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.AIDS. 1998 Aug 20;12(12):1451-7. doi: 10.1097/00002030-199812000-00006. AIDS. 1998. PMID: 9727565
-
[Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment].Ned Tijdschr Geneeskd. 1997 Jan 11;141(2):80-3. Ned Tijdschr Geneeskd. 1997. PMID: 9036351 Review. Dutch.
-
Disseminated mycobacterium avium-intracellulare complex (MAC) infection in the era of effective antiretroviral therapy: is prophylaxis still indicated?Drugs. 2004;64(7):679-92. doi: 10.2165/00003495-200464070-00001. Drugs. 2004. PMID: 15025543 Review.
Cited by
-
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.Pediatr Infect Dis J. 2013 Nov;32 Suppl 2(0 2):i-KK4. doi: 10.1097/01.inf.0000437856.09540.11. Pediatr Infect Dis J. 2013. PMID: 24569199 Free PMC article. No abstract available.
-
Age-dependent humoral responses of children to mycobacterial antigens.Clin Diagn Lab Immunol. 1995 Jul;2(4):443-7. doi: 10.1128/cdli.2.4.443-447.1995. Clin Diagn Lab Immunol. 1995. PMID: 7583921 Free PMC article.
-
Epidemiology of infection by nontuberculous mycobacteria.Clin Microbiol Rev. 1996 Apr;9(2):177-215. doi: 10.1128/CMR.9.2.177. Clin Microbiol Rev. 1996. PMID: 8964035 Free PMC article. Review. No abstract available.
-
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166. MMWR Recomm Rep. 2009. PMID: 19730409 Free PMC article.
-
Southern African HIV Clinicians Society guideline on the management of non-tuberculous mycobacteria in people with HIV.South Afr J HIV Med. 2024 Oct 23;25(1):1657. doi: 10.4102/sajhivmed.v25i1.1657. eCollection 2024. South Afr J HIV Med. 2024. PMID: 39507465 Free PMC article. No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials